| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |